| A549 | Human Lung Adenocarcinoma |
| AGS | Gastric Adenocarcinoma |
| AMPK | AMP Activated Protein Kinase |
| CACO | Human Colon Carcinoma |
| CCK | Cell Counting Kit |
| CDK | Cyclin Dependent Kinase |
| DAPI | 4′,6-Diamidino-2-Phenylindole |
| DCFH-DA | Dichlorodihydrofluorescein diacetate |
| DLA/DAL | Dalton’s Lymphoma Ascites/Dalton’s Ascites Lymphoma |
| DTP | Developmental Therapeutic Program |
| GSH | Glutathione |
| H1299 | Human Non-Small Cell Lung Cancer |
| HCT/HT | Human Colorectal Adenocarcinoma |
| HeLa | Henrietta Lacks Cervical Cancer |
| Hep | Human Epithelial |
| HL | Human Caucasian Promyelocytic Leukemia |
| IC50/EC50 | Concentration Required to Inhibit/Destroy 50% Cells |
| NF-kB | Nuclear Factor-Kappa B |
| MCF | Human Breast Adenocarcinoma |
| MCL | Myeloid Cell Leukemia |
| MDA-MB | M. D. Anderson Metastasis Breast Cancer |
| MMP | Matrix Metallopeptidase |
| MST | Mean Survival Time |
| MTT | 3-[4,5-Dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide |
| OSA | Osteosarcoma |
| PARP | PolyADP-ribosepolymerase |
| PC | Prostate Cancer |
| PKC | Protein Kinase C |
| SRB | Sulforhodamine B |
| STAT | Signal Transducer and Activator of Transcription |
| T47D | Ductal Epithelial Breast Tumor |
| TBE | Trypan Blue Exclusion |
| THP | Human Acute Monocytic Leukemia |
| VEGF | Vascular Endothelial Growth Factor |
| Vero | Verda Reno |
| WM | Malignant Melanoma |
| WST | Water Soluble Tetrazolium |
| XTT | Cell Proliferation Kit II |